469 related articles for article (PubMed ID: 10937835)
1. 4-Hydroxytamoxifen-induced cytotoxicity and bisphenol A: competition for estrogen receptors in human breast cancer cell lines.
Lewis JB; Lapp CA; Schafer TE; Wataha JC; Randol TM; Schuster GS
In Vitro Cell Dev Biol Anim; 2000 May; 36(5):320-6. PubMed ID: 10937835
[TBL] [Abstract][Full Text] [Related]
2. Differential activation of wild-type and variant forms of estrogen receptor alpha by synthetic and natural estrogenic compounds using a promoter containing three estrogen-responsive elements.
Yoon K; Pallaroni L; Stoner M; Gaido K; Safe S
J Steroid Biochem Mol Biol; 2001 Jul; 78(1):25-32. PubMed ID: 11530281
[TBL] [Abstract][Full Text] [Related]
3. Effects of the environmental estrogens bisphenol A, o,p'-DDT, p-tert-octylphenol and coumestrol on apoptosis induction, cell proliferation and the expression of estrogen sensitive molecular parameters in the human breast cancer cell line MCF-7.
Diel P; Olff S; Schmidt S; Michna H
J Steroid Biochem Mol Biol; 2002 Jan; 80(1):61-70. PubMed ID: 11867264
[TBL] [Abstract][Full Text] [Related]
4. Estrogen-like properties of brominated analogs of bisphenol A in the MCF-7 human breast cancer cell line.
Samuelsen M; Olsen C; Holme JA; Meussen-Elholm E; Bergmann A; Hongslo JK
Cell Biol Toxicol; 2001; 17(3):139-51. PubMed ID: 11693576
[TBL] [Abstract][Full Text] [Related]
5. High concentrations of bisphenol A induce cell growth and prolactin secretion in an estrogen-responsive pituitary tumor cell line.
Chun TY; Gorski J
Toxicol Appl Pharmacol; 2000 Feb; 162(3):161-5. PubMed ID: 10652244
[TBL] [Abstract][Full Text] [Related]
6. Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells.
Katzenellenbogen BS; Norman MJ; Eckert RL; Peltz SW; Mangel WF
Cancer Res; 1984 Jan; 44(1):112-9. PubMed ID: 6537799
[TBL] [Abstract][Full Text] [Related]
7. Effects of bisphenol A-related diphenylalkanes on vitellogenin production in male carp (Cyprinus carpio) hepatocytes and aromatase (CYP19) activity in human H295R adrenocortical carcinoma cells.
Letcher RJ; Sanderson JT; Bokkers A; Giesy JP; van den Berg M
Toxicol Appl Pharmacol; 2005 Dec; 209(2):95-104. PubMed ID: 15907334
[TBL] [Abstract][Full Text] [Related]
8. The food contaminants bisphenol A and 4-nonylphenol act as agonists for estrogen receptor alpha in MCF7 breast cancer cells.
Vivacqua A; Recchia AG; Fasanella G; Gabriele S; Carpino A; Rago V; Di Gioia ML; Leggio A; Bonofiglio D; Liguori A; Maggiolini M
Endocrine; 2003 Dec; 22(3):275-84. PubMed ID: 14709801
[TBL] [Abstract][Full Text] [Related]
9. Bisphenol a binds to the low-affinity estrogen binding site.
Washington W; Hubert L; Jones D; Gray WG
In Vitr Mol Toxicol; 2001; 14(1):43-51. PubMed ID: 11689155
[TBL] [Abstract][Full Text] [Related]
10. Estrogenic and antiestrogenic activities of flavonoid phytochemicals through estrogen receptor binding-dependent and -independent mechanisms.
Collins-Burow BM; Burow ME; Duong BN; McLachlan JA
Nutr Cancer; 2000; 38(2):229-44. PubMed ID: 11525602
[TBL] [Abstract][Full Text] [Related]
11. Estrogenic activity of octylphenol, nonylphenol, bisphenol A and methoxychlor in rats.
Laws SC; Carey SA; Ferrell JM; Bodman GJ; Cooper RL
Toxicol Sci; 2000 Mar; 54(1):154-67. PubMed ID: 10746942
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo interactions of bisphenol A and its metabolite, bisphenol A glucuronide, with estrogen receptors alpha and beta.
Matthews JB; Twomey K; Zacharewski TR
Chem Res Toxicol; 2001 Feb; 14(2):149-57. PubMed ID: 11258963
[TBL] [Abstract][Full Text] [Related]
13. Environmental fate of bisphenol A and its biological metabolites in river water and their xeno-estrogenic activity.
Suzuki T; Nakagawa Y; Takano I; Yaguchi K; Yasuda K
Environ Sci Technol; 2004 Apr; 38(8):2389-96. PubMed ID: 15116845
[TBL] [Abstract][Full Text] [Related]
14. Estrogenic activity of naturally occurring anthocyanidins.
Schmitt E; Stopper H
Nutr Cancer; 2001; 41(1-2):145-9. PubMed ID: 12094617
[TBL] [Abstract][Full Text] [Related]
15. Agonist-antagonist activity of anti-estrogens in the human breast cancer cell line MCF-7: an hypothesis for the interaction with a site distinct from the estrogen binding site.
Berthois Y; Pons M; Dussert C; Crastes de Paulet A; Martin PM
Mol Cell Endocrinol; 1994 Mar; 99(2):259-68. PubMed ID: 8206333
[TBL] [Abstract][Full Text] [Related]
16. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
Miller MA; Lippman ME; Katzenellenbogen BS
Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
[TBL] [Abstract][Full Text] [Related]
17. Estrogenic activity of the phytoestrogens naringenin, 6-(1,1-dimethylallyl)naringenin and 8-prenylnaringenin.
Zierau O; Gester S; Schwab P; Metz P; Kolba S; Wulf M; Vollmer G
Planta Med; 2002 May; 68(5):449-51. PubMed ID: 12058324
[TBL] [Abstract][Full Text] [Related]
18. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS
Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652
[TBL] [Abstract][Full Text] [Related]
19. Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol.
Nagel SC; vom Saal FS; Thayer KA; Dhar MG; Boechler M; Welshons WV
Environ Health Perspect; 1997 Jan; 105(1):70-6. PubMed ID: 9074884
[TBL] [Abstract][Full Text] [Related]
20. Relationship between estrogen receptor-binding and estrogenic activities of environmental estrogens and suppression by flavonoids.
Han DH; Denison MS; Tachibana H; Yamada K
Biosci Biotechnol Biochem; 2002 Jul; 66(7):1479-87. PubMed ID: 12224631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]